China Jo-Jo Drugstores Files 6-K

Ticker: RDGT · Form: 6-K · Filed: Mar 19, 2024 · CIK: 1856084

China Jo-Jo Drugstores, Inc. 6-K Filing Summary
FieldDetail
CompanyChina Jo-Jo Drugstores, Inc. (RDGT)
Form Type6-K
Filed DateMar 19, 2024
Risk Levellow
Pages1
Reading Time1 min
Sentimentneutral

Sentiment: neutral

Topics: filing, 6-K, company-update

TL;DR

China Jo-Jo Drugstores filed a 6-K with a press release on March 19, 2024.

AI Summary

China Jo-Jo Drugstores, Inc. filed a Form 6-K on March 19, 2024, to furnish a press release dated March 19, 2024. The company, previously known as China Jo-Jo Drugstores Holdings, Inc., is a Cayman Islands exempted company based in Hangzhou, China.

Why It Matters

This filing indicates ongoing reporting activity for China Jo-Jo Drugstores, Inc., providing investors with updated information.

Risk Assessment

Risk Level: low — This is a routine filing (6-K) that primarily serves to furnish an exhibit, with no immediate indication of significant financial or operational changes.

Key Players & Entities

  • China Jo-Jo Drugstores, Inc. (company) — Registrant
  • China Jo-Jo Drugstores Holdings, Inc. (company) — Former company name
  • March 19, 2024 (date) — Filing and press release date
  • 001-40724 (other) — SEC File Number

FAQ

What is the purpose of this Form 6-K filing?

The Form 6-K is being filed to furnish a press release dated March 19, 2024, as an exhibit.

What is the company's current name and former name?

The company's current name is China Jo-Jo Drugstores, Inc., and its former name was China Jo-Jo Drugstores Holdings, Inc.

When was the company's name changed?

The date of the name change was April 8, 2021.

Where is the company's principal executive office located?

The company's principal executive offices are located at 4th Floor, Building 5, Renxin Yaju, Gong Shu District, Hangzhou City, Zhejiang Province, People's Republic of China, 310014.

Does the company file annual reports under Form 20-F or 40-F?

The company indicates it files annual reports under Form 20-F.

Filing Stats: 190 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-03-19 16:05:02

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: March 19, 2024 CHINA JO-JO DRUGSTORES, INC. By: /s/ Lei Liu Name: Lei Liu Title: Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.